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Abstract
Healthcare is a natural arena for the application of machine learning, especially as
modern electronic health records (EHRs) provide increasingly large amounts of
data to answer clinically meaningful questions. However, clinical data and prac-
tice present unique challenges that complicate the use of common methodologies.
This article serves as a primer on addressing these challenges and highlights op-
portunities for members of the machine learning and data science communities to
contribute to this growing domain.
1 Introduction
Health problems are foundational issues in human lives. When medical care is given, care staff
collect clinical data about the particular patient being seen, and leverage knowledge from the general
population, to determine how to treat the patient. Data thus plays a fundamental role in addressing
health problems, and improved information extraction is a crucial part of better treating patients.
Using data, machine learning has driven advances in many domains including computer vision,
natural language processing (NLP), and automatic speech recognition (ASR) to deliver powerful
systems (e.g., driverless cars, voice activated personal assistants, automated translation). Machine
learning’s ability to extract information from data, paired with the centrality of data in healthcare,
makes research in machine learning for healthcare crucial.
Interest in machine learning for healthcare has grown immensely, including work in diagnosing
diabetic retinopathy (Gulshan et al., 2016), detecting lymph node metastases from breast pathology
(Golden, 2017), autism subtyping by clustering comorbidities (Doshi-Velez et al., 2014), and large-
scale phenotyping from observational data (Pivovarov et al., 2015). Despite these advances, direct
application of machine learning to healthcare remains fraught with many pitfalls. Many of these
challenges stem from the nominal goal in healthcare to make personalized predictions using large
amounts of noisy and biased data. However, the opportunity to create high-impact solutions presents
technical opportunities that are likely to be meaningful.
In this paper we present the unique challenges, and the ensuing technical and clinical opportunities,
inherent to clinical data. In Sections 2 and 3, we provide an overview of clinical data types, and cover
the unique technical challenges that should be considered in machine learning systems for healthcare
tasks. The failure to carefully consider these challenges can hinder the validity and utility of machine
learning methods. In Section 4, we present a hierarchy of clinical opportunities, organized into the
following general categories: automating clinical tasks, providing clinical support, and expanding
clinical capacities. Finally, in Section 5 we outline the novel opportunities for new research machine
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learning that have particular relevance in healthcare: accommodating shifts in data sources and
mechanisms, ensuring models are interpretable, and identifying good representations.
2 The Promise and Perils of Clinical Data
Clinical data comes in a variety of forms which can be relevant to understanding patient health
(Weber et al., 2014). We focus on the electronic health record (EHR) that documents care delivered.
EHRs are primarily designed to support day-to-day operational needs such as tracking care and
revenue cycle management (i.e., billing and payments), and contain heterogeneous data types. In
acute care, they range from high-frequency data sampled hundreds of times per second, to vital signs
that are noted hourly, to laboratory tests that are recorded when the clinicians order them, to notes
that are written every twelve hours, to more static demographic data. These large differences in data
type, time scale, and sampling rates make modeling challenging. Clinical data is almost exclusively
documented without machine learning in mind, and are collected under a policy of interventions to
improve patients’ health. Each data type comes with its own challenges, some of which we outline
below.
High-frequency monitors record real-time data at a patient’s bedside. High-frequency mon-
itors record clinical signals data like oxygen saturation. These signals have frequent artifact cor-
ruption (e.g., from sensors falling off), and must be aggregated, filtered, or discarded to remove
artifacts prior to any learning or feature extraction. For example, electrocardiogram (ECG) sig-
nal acquired in the US must be be filtered at 60 Hz to remove power grid electrical interference
(Nimunkar and Tompkins, 2007). While clinical signals can be collected with minimal human inter-
action, they provide only a narrow view of patient state.
Vitals and labs measure biomarkers of a patient’s state. Vital signs, laboratory tests, and other
numerical measurements that are noted by clinical staff are often irregularly ordered and subject
to sporadic over-sampling. Non-invasive values can conflict with the high-frequency invasive data
(Li-wei et al., 2013), or staff may feel that they have a general sense of patient state, and preferen-
tially record results that are consistent with that understanding (Hug et al., 2011). Moreover, clini-
cians order laboratory tests related to the amount of variability they expect in the test (Hripcsak et al.,
2015). For example, the absolute time that a laboratory measurement occurs can be more predictive
of patient health than the value of the test (Weber and Kohane, 2013; Agniel et al., 2018); e.g., a
clinician will probably only wake you at 2 am to perform a blood test if you are very ill.
Notes record the interaction between a patient and the healthcare team. The narrative in the
clinical notes, recorded by expert care staff, is designed to provide trained professionals a quick
glance into the most important aspects of a patient’s clinical condition. However, standard natural
language processing tasks such as sentiment analysis and word sense disambiguation are difficult
in clinical notes, which are misspelled, acronym-laden, and copy-paste heavy (Cohen et al., 2013,
2014). Even clinical NLP packages designed to process clinical text can be misled (Savova et al.,
2010). For example, a clinical NLP tool trained on a large corpus of medical text may incorrectly
identify many autistic patient records with cancer. This is because the term “T2” is the clinical term
for a stage of cancer progression (Winawer et al., 1997), but “T2” also describes one output modality
of MRI that is used to diagnose autism in children (Courchesne et al., 2001).
3 Unique Technical Challenges in Healthcare Tasks
In tackling healthcare tasks, there are important factors that should be considered carefully in the
design and evaluation of machine learning projects, causality, missingness, and outcome definition.
These considerations are important across both modeling frameworks (e.g., supervised vs. unsuper-
vised), and learning targets (e.g., classification vs. regression).
3.1 Understanding Causality is Key
Many of the most important and exciting problems in healthcare require algorithms that can answer
causal, “what if?” questions about what will happen if a doctor administers a treatment. These
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questions are beyond the reach of classical learning algorithms because they require a formal model
of interventions. Instead, we need to reason about and learn from data through the lens of causal
models (e.g., see Pearl 2009). Learning from data to answer causal questions is most challenging
when the data are collected observationally; that is, it may have been influenced by the actions of an
agent whose policy for choosing actions is not known.
In healthcare, learning is done almost exclusively using observational data, which poses a number
of challenges to building models that can answer causal questions. For instance, Simpson’s paradox
describes the observation that the relationship between two variables can change directions if more
information is included in the model (Pearl, 2009). To better understand this issue, consider prior
work in which researchers found that asthmatic patients who were admitted to the hospital for pneu-
monia were more aggressively treated for the infection, lowering the subpopulation mortality rate
(Cooper et al., 2005). A model that predicts death from asthma will learn that asthma is protective.
If, however, an additional variable to account for the level of care is included, the model may instead
find that having asthma increases the risk of death. To account for these challenges, strong assump-
tions must be made that cannot be statistically checked or validated; i.e., gathering more data will
not help (Greenland et al., 1999). The shortcomings of classical statistical learning when answering
causal questions are discussed in greater detail by Pearl (2018).
3.2 Models in Health Must Consider Missingness
Even if all important variables are included in a healthcare dataset, it is likely that many observations
will be missing. Truly complete data is often impractical due to cost and volume. Learning from in-
complete, or missing, data has received relatively little attention in the machine learning community
(exceptions include, e.g., Marlin et al. 2011; Mohan et al. 2013; McDermott et al. 2018), but is an
actively studied topic in statistics (e.g., Ding and Li 2018).
There are three widely accepted classifications of missing data mechanisms; i.e., the measurement
mechanism determining whether a value is recorded or not (Little and Rubin, 2014). The first, miss-
ing completely at random (MCAR), posits a fixed probability of missingness. In this case, dropping
incomplete observations — known as complete case analysis — is commonly used (albeit naively),
and will lead to unbiased results. Second, the data may be missing at random (MAR), where the
probability of missingness is random conditional on the observed variables. In this case, common
methods include re-weighting data with methods like inverse probability of censoring weighting or
using multiple imputations to in-fill (Robins, 2000; Robins et al., 2000). Finally, data may be miss-
ing not at random (MNAR), where the probability of missingness depends on the missing variable
itself, or other missing and unobserved variables. This setting requires strong assumptions about the
measurement policy to successfully circumvent (Little and Rubin, 2002).
In designing a learning algorithm in a healthcare setting, the sources of missingnessmust be carefully
understood. For example, lab measurements are typically ordered as part of a diagnostic work-up,
meaning that the presence of a datapoint conveys information about the patient’s state. Consider a
hospital where clinical staff measures patient lactate level. If a power outage led to a set of lactate
levels being lost, the data are MCAR. If nurses are less likely to measure lactate levels in patients
with traumatic injury, and we record whether patients were admitted with trauma, the data are MAR.
However, if nurses are less likely to measure lactate levels in patient who they believe have low
levels, then the lactate measures themselves are MNAR, and the measurement of the signal itself
is meaningful. The key feature of missing data is that there may be information conveyed by the
absence of an observation, and ignoring this dependence may lead to models that make incorrect,
and even harmful, predictions.
3.3 Make Careful Choices in Defining Outcomes
Obtaining reliable outcomes for learning is an important step in defining tasks. Outcomes are often
used to create the gold-standard labels needed for supervised prediction tasks, but are crucial in other
settings as well, e.g., to ensure a well-defined cohorts in a clustering task. There are three key factors
to consider with outcome definitions: creating reliable outcomes, understanding the relevance of an
outcome clinically, and the subtlety of label leakage in clinical data.
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Create reliable outcomes from heterogeneous source data. Multiple data sources should be con-
sidered when creating labels in healthcare because EHRs often lack precise structured labels. Or, in
some cases, structured labels may be available, but unreliable (O’malley et al., 2005). For example,
a diagnostic clinical code for pneumonia could mean a patient was screened for pneumonia rather
than that they actually had pneumonia, e.g., a 2013 study found that sensitivity and specificity for
a community-acquired pneumonia diagnostic code could be as low as 60% and 75%, respectively
(Williams et al., 2013). Machine learning methods to pool different data types and obtain a more
reliable label is known as phenotyping (Richesson et al., 2013), and is an important subfield of ma-
chine learning in healthcare (Halpern et al., 2016; Yu et al., 2017). Recent work has emphasized
the need to integrate the rich information available in clinical notes, and building natural language
processing pipelines to extract information from unstructured clinical text accurately is an active
subject of research (Savova et al., 2010).
Understand the outcome in context of a healthcare system. Medical definitions are working
models using the current scientific understanding of a disease. As the field’s understanding evolves,
so does the definition. The implication for machine learning is that good predictive performance
on labels based on such definitions is only as good as the underlying criteria. For example, acute
kidney injury (AKI) is an important critical illness with two recent definitions: RIFLE and KDIGO
(Ricci et al., 2008; Khwaja, 2012). Another condition, septic shock, has received considerable atten-
tion frommachine learning researchers (e.g., Henry et al. 2015; Futoma et al. 2017), and has been re-
defined several times over the last two decades (Levy et al., 2003; Dellinger et al., 2013; Singer et al.,
2016). Similarly, it is tempting to use the actual behavior of clinicians as correct labels, but it is im-
portant to remember that they may not be. For example, work that targets prediction of clinical
actions must carefully consider whether the treatments are good labels, and whether “incorrect pre-
dictions” are in fact forecasting treatments that would have been given by other clinicians rather than
treatments that would optimally treat the patient (Ghassemi et al., 2016, 2017; Suresh et al., 2017).
Beware of label leakage. The information collected in an individual’s hospital encounter is tightly
coupled across time, and this can result in information about the targeted task outcome leaking
back into possible features (e.g., Razavian et al. 2016). While exploiting such relationships between
features and targets is a goal of learning, information leakage can render a prediction useless. For
example, consider predicting mortality of hospital patients using all available data up until their time
of death. Such a task could lead to a pathological prediction rule — “if the ventilator is turned off in
the preceding hour, predict death.” This commonly happens when patients and their families decide
to withdraw care at a terminal stage of illness. A machine learning algorithm trained naively on
this signal would have extremely high predictive performance by nearly any metric, yet would have
absolutely no clinical utility.
4 Addressing a Hierarchy of Healthcare Opportunities
There are many high-impact opportunities in healthcare, and before fitting models, goals should be
clearly identified and validated as worth solving. Here, we frame potential healthcare opportunities
into three high-level categories: automating clinical tasks, providing clinical support, and expanding
clinical capacities. We note that the details of how a technical solution is deployed can change its in-
tent, (e.g., from automation to support) and that it is therefore crucial to engage clinical stakeholders
early on.
4.1 Clinical Task Automation: Automating clinical tasks during diagnosis and treatment
There are many tasks currently performed by clinicians that present low-hanging fruit for machine
learning researchers. Clinical task automation encompasses a class of work that clinicians currently
do. These tasks are well-defined (i.e., known input and output spaces), and thus require the least
amount of domain adaptation and investment. The evaluation of task replacement is also straightfor-
ward — models map directly onto a task or decision that clinicians are currently capable of doing
with a high degree of accuracy, and performance should be measured against existing standards. We
emphasize that algorithms should replace clinical staff, but rather be used to optimize the clinical
workflow. Clinical roles will likely evolve as these techniques improve, empowering staff to spend
more time on patient interaction and well-being (Jha and Topol, 2016).
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Automating medical image evaluation. Medical imaging is a natural opportunity for machine
learning because clinicians undergo intensive training to map from a fixed input space (e.g. the
images) to an output (e.g. the diagnosis). There have been several recent successes in applying deep
learning to medical imaging tasks. For example, physician-level parity in the detection of diabetic
retinopathy (Gulshan et al., 2016), distinguishing betweenmalignant and non-malignant skin lesions
using in dermatoscopic images (Esteva et al., 2017), detecting lymph node metastases from breast
pathology slides (Golden, 2017), and detecting hip fractures in x-ray images (Gale et al., 2017).
Automating routine processes. Similarly, automating routine clinical processes stands to reduce
the burden place on clinical staff who are already pressed for time. For example, prioritizing triage
order in the emergency department is often left to staff (Ieraci et al., 2008), but could be done algo-
rithmically. Likewise, summarizing the contents of patients’ medical records (McCoy et al., 2018)
is a time-consuming, but valuable, task. For example, when hospital staff are unsure about patient’s
disease status, they may call for an infectious disease consultation in which a specialist meticulously
reviews all the available patient data, and manually summarizes disparate sources into a series of
recommended tests and treatments (Forsblom et al., 2012).
4.2 Clinical Support and Augmentation: Optimizing clinical decision and practice support
Another set of opportunities focus on supporting and augmenting clinicians as they provide care.
Rather than replacing a well-defined task, support requires understanding clinical pain points and
working with clinical staff to understand appropriate input data, output targets and evaluation func-
tions. The opportunities for support in healthcare focus on work that often suffers due to real-world
constraints on time and resources, often leading to information loss and errors (e.g., mistaken patient
identification, flawed interpretations, or incorrect recall (Shneiderman et al., 2013)). In this setting,
it is most appropriate to evaluate howmodels improve downstream outcomes in tandemwith clinical
input rather than head-to-head comparisons to clinical staff (Pivovarov et al., 2016).
Standardizing clinical processes. Variations in clinical training and experience lead to ranges of
treatment choices that may not be optimal for targeting the underlying maladies of a patient’s state.
For example, clinical staff may be unsure which medication sets or doses are most appropriate for a
patient (Fishbane et al., 2007). To support such needs, past work has examined recommending both
standardized order sets to help care staff quickly assess what medications they may have missed
(Halpern, 2016) and default dosages to avoid dangerous dosing (Bates and Gawande, 2003).
Integrating fragmented records. Finite resources can also lead to a lack of communication and
coordination, affecting patient care. For example, because healthcare delivery is often fragmented,
it can take years to identify domestic abuse survivors because any single clinical visit in isolation
will be consistent with many other likely causes (e.g. admission to an emergency department due
to bruising is consistent with a spontaneous fall). Only a thorough review of a patient’s record will
demonstrate the pattern of repeated admissions and other indicators (Kyriacou et al., 1999) (e.g.,
parters’ alcohol abuse). While possible without support systems in principle, machine learning can
be a powerful tool in aiding clinical staff by identifying patients with high risk, e.g., identifying
domestic abuse up to 30 months in advance of the healthcare system (Reis et al., 2009).
4.3 Expanding Clinical Capacities: New horizons in screening, diagnosis and treatment.
As healthcare records become increasingly digitized, clinicians are faced with an ever-increasing
amount of novel data for patients and populations. In this explosion of availability, there is an
opportunity to give the healthcare system a new set of capacities that deliver healthcare in better
and smarter ways. Importantly, creating new capacities require the most involvement with clinical
collaborators; as researchers work to create new tools using previously unavailable or unused data,
impact should be measured both in innovation and clinical value.
Expanding the coverage of evidence. While healthcare is an inherently data-driven field, most
clinicians operate with limited evidence guiding their decisions. Randomized trials estimate av-
erage treatment effects for a trial population, but numerous day-to-day clinical decisions are not
based on high-quality randomized control trials (RCTs) (Landoni et al., 2015). For example, the ma-
jority of commonly used ICU treatments are not rigorously empirically validated (McGinnis et al.,
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2013); some analysts have estimated that only 10–20% (Mills et al., 2013) of treatments are backed
by an RCT. Even in settings where an RCT exists, the trial population tends to be a narrow, fo-
cused subgroup defined by the trial’s inclusion criteria (Travers et al., 2007), but that cohort may
not be representative of the much more heterogeneous population to which trial results are then ap-
plied (Phillips and Hamberg, 2016). Finally, RCT results cannot reflect the complexity of treatment
variation because, in practice, patient care plans are highly individualized. Prior work found that
approximately 10% of diabetes and depression patients and almost 25% of hypertension patients
had a unique treatment pathway (i.e., zero nearest neighbors) in a cohort of 250 million patients
(Hripcsak et al., 2016). One way forward would be to leverage this naturally occurring heterogene-
ity to design natural experiments (Angrist and Pischke, 2008) that approximate the results of an RCT
using fewer resources, thereby allowing a much larger set of clinical questions to be investigated.
Moving towards continuous behavioral monitoring. Phenotyping is an important goal in health-
care (Richesson et al., 2013), and wearable data provides an ongoing way for devices to collect con-
tinuous non-invasive data and providemeaningful classifications or alerts when the patient is in need
of clinical attention. Recent work has focused on predicting such varied outcomes as heart attack
from routinely collected data (Weng et al., 2017) and hydrocephalus from fetal MRI (Pisapia et al.,
2017). There are further settings where non-invasive monitoring may be the only practical way to
provide detection. For example, automatic fall detection for geriatric patients, or enforcing hand
washing compliance in a clinical setting (Haque et al., 2017). Importantly, prior challenges identi-
fied in label leakage, soft labels, confounding and missingness must be considered very carefully. In
the case of phenotyping chronic conditions, patients with a disease are often already being treated
for that disease, and so early detectionmay sometimes amount to identifying an existing treatment—
e.g. looking at longitudinal patterns of heart rate data to detect hypertension may really be detecting
the use of beta blockers (used to treat hypertension) (Ballinger et al., 2018).
Precision medicine for early individualized treatment. Precision medicine seeks to individual-
ize the treatment of each patient; this is particularly important in the case of syndromes — medical
conditions defined by a collection of symptoms whose causes are unknown (Council, 2011). For
instance, acute kidney injury (AKI) is defined by a collection of symptoms characterizing kidney
failure, not an underlying cause (Kellum and Prowle, 2018). Two individuals may have developed
AKI for different reasons because there are many reasons that kidneys can fail. More measurements
of the two individuals could reveal the difference in cause, which may in turn suggest alternative
treatment strategies (Alge and Arthur, 2014). By personalizing over time, one can learn individual-
specific treatment effects that address the cause of the syndrome (Xu et al., 2016; Schulam and Saria,
2017) in a particular individual. This relates to the ideas from “N = 1” crossover studies in exper-
imental design (Araujo et al., 2016). Personalized treatment is enabled by growing repositories of
longitudinal data, where long-term progressions of an individual’s health are available. However,
new memory models are needed for sequence prediction tasks, because such records are not evenly
spaced, can cover very long durations, and early events can affect patient state many years later.
Personalized patient models that target improved early stage of prediction could also leverage popu-
lation level information, drawing on work in “cold starting” recommendation systems (Park and Chu,
2009).
5 Opportunities for New Research in Machine Learning
Addressing the hierarchy of opportunities in healthcare creates numerous technical opportunities for
innovation. Importantly, clinical staff and machine learning researchers often have complementary
sets of skills, and many high-impact problems can only be tackled by collaborative efforts. Further,
many of the inherent properties that are highly desirable in healthcare (e.g., interpretability) are likely
to be important in other domains. Here we note several promising directions of research in machine
learning for healthcare, specifically highlighting those that address issues of data non-stationarity,
model interpretability, and discovering appropriate representations.
5.1 Accommodating Data and Practice Non-stationarity in Learning and Deployment
In most existing work, models are trained on the largest dataset possible and assumed to be fit
for deployment, i.e., once the model is in production, it does not keep learning. This is particularly
6
problematic in clinical settings, because patient populations and recommended treatment procedures
will change over time, resulting in degraded predictive performance as the statistical properties of
the target change. For example, clinicians previously assumed that estrogen was cardioprotective in
menopausal women (Gabriel Sanchez et al., 2005) and hormone therapy was routinely prescribed as
a preventative measure until large trials reported either no benefit or an increase in adverse cardiac
events (Prentice et al., 2006). In developing newmodels for healthcare, models must be made robust
to these changes, or acknowledge their mis-calibration for the new population (Tsymbal, 2004).
Internal Validity - Shift over time. In a notable example of concept drift, Google Flu Trends
persistently overestimated flu due to shifts in search behaviors (Lazer et al., 2014). In this case, the
initial model was a great success, leveraging Google search data to predict flu incidence; however,
without update the model began to overestimate flu incidence in subsequent years as user search
behaviors had shifted. While the drift in this case was unintentional, the example serves to motivate
the need for models that continually update as population characteristics naturally evolve over time.
External Validity - Shift over sources. There is also no reason to believe a priori that a model
learned from one hospital will generalize to a new one. Many factors impact generalizability, includ-
ing local hospital practices, different patient populations, available equipment, and even the specific
kind of EHR each uses. Even within the same hospital, transitions from one medical record system
to another create non-obvious feature mapping problems, which themselves warrant machine learn-
ing (Gong et al., 2017). This issue will remain until infrastructure to easily test across multiple sites
and health systems becomes prevalent. The absence of such standardization creates opportunities
with respect to data normalization, the development of models that are robust to — and potentially
able to exploit — differences in data collection at different sites.
Creating models robust to feedback loops. Models that learn from existing clinical practice are
susceptible to amplifying the biases endemic to modern healthcare. While not yet observed in health-
care, such feedback loops have been noted in the deployment of predictive policing (Lum and Isaac,
2016). Such biases reflected in deployed predictions can propagate into future training data, effec-
tively creating a feedback loop that causes further bias (Dressel and Farid, 2018). While still in its
infancy, work in algorithmic fairness should be considered as it motivates the need for systems that
are sufficiently aware that they can alert us to such unwanted behavior.
5.2 Creating interpretable models and recommendations
In a clinical setting, black box methods present new challenges. Traditionally, quantitative training
has not been emphasized in a physician’s extensive medical training (Obermeyer and Lee, 2017)
and most physicians do not have a robust understanding of rubrics such as positive predictive value
(Manrai et al., 2014). Models cannot be deployed “in the wild” at a low cost, and clinical staff must
justify deviations in treatment to satisfy both clinical and legal requirements.
Defining what interpretibility means. There are many possible ways to interpretability, e.g.,
through feature space minimization, model regularization, or a preference for particular classes of
models that have well-known post-hoc analysis methods (Doshi-Velez and Kim, 2017). For exam-
ple, providing a posterior distribution over possible decision lists (e.g., “if hemiplegia and age > 60
then stroke risk is 58.9%, else if...”) (Letham et al., 2015). Such lists can provide a natural way for
clinicians to think about the relative risks of their patient’s condition.
Moving from interpretation to justification. In other domains, many forms of interpretability
rely on human expertise in the subject matter, e.g., a model may highlight a single sentence from
a user review (“The coffee is wonderful.”) as the rationale for a review prediction. Clinicians are
unlikely to have a similar contextual framework, and it is unlikely to be obvious what a particular
pattern of lab measurements that maximally activates a models means, biologically or clinically
(Suresh et al., 2017). We argue that models should instead provide “justifiability”; beyond explain-
ing a specific prediction, models should strive towards justifying the predictive path itself. For exam-
ple, global decision boundaries are often non-linear and complex, but recent work has proposed that
locally-interpretable results can be presented for each individual prediction (Ribeiro et al., 2016).
Another possibility is learning influence functions to trace a model’s prediction through the learn-
ing algorithm and back to its training data, thereby identifying training points most responsible for
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a given prediction (Koh and Liang, 2017). Outside of reassuring end users, justifying a machine
learning algorithm’s decision is also important for security concerns. It has recently been argued
that medicine may be uniquely vulnerable to “adversarial attacks” (Finlayson et al., 2018), thus it is
crucial that algorithms justify their outputs to help identify if a system is being compromised.
Adding interaction to machine learning and evaluation. Machine learning work in healthcare
has an opportunity to create systems that interact and collaborate with human experts. Clinical
staff provide more than their expertise; they also act as caregivers, and empathy is recognized as
an important element of clinical practice (e.g. Charon 2001; Stewart 2003). Building collaborative
systems can leverage the complementary strengths of physicians and learning systems. There are
many threads of research in the machine learning literature that can serve as a foundation for such
systems. In active learning, for example, the goal is to leverage an oracle in order to learn using fewer
samples (Settles, 2012). Apprenticeship learning is another related set of ideas (e.g. Abbeel and Ng
2004). The study of collaborative systems, where the human and machine work together, is still in its
early stages. Examples of such systems include content creation algorithms that alternate back and
forth between human and machine proposals (Cho, 2002), and intelligent, data-driven operations for
drawing software (Zhu et al., 2016).1
5.3 Identifying Representations in a Large, Multi-source, Network
Representation learning has prompted great advances in machine learning; for example, the lower
dimensional, qualitatively meaningful representations of imaging datasets learned by convolutional
neural networks. Healthcare data lacks such obviously natural structures, and investigations into ap-
propriate representations should include multi-source integration, and learning domain appropriate
representations.
Integrating predictions from multi-source high-dimensional data. Individual patient data has
ballooned to include many sources and modalities, making integration more challenging in sys-
tems currently struggling with overload (Obermeyer and Lee, 2017; Beam and Kohane, 2018). Us-
ing high-dimensional data to make well-calibrated predictions of established risks is a way that
researchers can contribute. For example, inferring drug-resistance status in tuberculosis from
whole-genome sequencing data (Chen et al., 2018), predicting cardiovascular risk from EHR data
(Ranganath et al., 2016; Weng et al., 2017), readmission and mortality risk from longitudinal EHR
data (Rajkomar et al., 2018; Harutyunyan et al., 2017), prediction of hydrocephalus from fetal MRI
(Pisapia et al., 2017), and predicting cardiovascular risk from retinal images (Poplin et al., 2018).
Learning meaningful representations for the domain. Learning meaningful state representa-
tions that provide both good predictive performance in diverse tasks, and understand many condi-
tional relationships of interest, is an important area of focus in healthcare. Dealing with representa-
tions explicitly may be advantageous because they can conveniently express general priors that are
not specific to a single predictive task (Bengio et al., 2013), and this is particularly important for
zero-shot learning (Socher et al., 2013) in unseen categories. There are several potential opportuni-
ties to address in representations for a clinical setting. First, a single patient input (e.g., physiological
data) can correspond to many possible correct outputs (e.g., diagnostic codes), and this must be pos-
sible in the representations we explore. Additionally, there is likely value in incorporating structure
and domain knowledge into representation learning. There has also been some initial exploration
into learning representations of other data types that simultaneously capture hierarchy and similar-
ity (Nickel and Kiela, 2017), and recent work has examined using diagnostic code ontologies to aid
prediction (Choi et al., 2017), and adding nodes to the hidden layer of neural network models based
on known biological relationships between genes (Lin et al., 2017).
6 Conclusion
The effective use of machine learning in healthcare presents many challenges and opportunities for
researchers, and the potential impact is vast. In this work, we give a practical guide that researchers
can engage with as they begin work in healthcare. We emphasize that there are many opportunities
1https://jods.mitpress.mit.edu/pub/issue3-case
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for machine learning researchers to collaborate with clinical staff, and encourage researchers to
engage with clinical experts early on as they identify and tackle important problems.
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